Flotek Industries Inc/cn/ (FTK) · Nov 3, 2026 · Earnings

Flotek earnings beat estimates as 2026 guidance jumps again

Beat — Diluted EPS $0.34 vs ~$0.22 consensus; revenue $114.4M vs ~$94.4M

Flotek’s Q3 earnings beat consensus by a wide margin, while another guidance increase supports its data-analytics expansion story.

Flotek is in the middle of an industrial pivot: chemistry still supplies the bulk of revenue, while Data Analytics is the higher-margin growth engine being expanded into power generation, measurement, and infrastructure applications. The Q3 release materially advances that story: revenue more than doubled, the company beat the published quarterly consensus, and management raised full-year targets for the third time.

The operating beat was substantial, not cosmetic. Q3 revenue reached $114.4 million versus published consensus of about $94.4 million, while diluted EPS was $0.34 versus roughly $0.22 expected. Revenue growth came from both segments, with Chemistry Technologies up 104% and Data Analytics also up 104% year over year (Segment results). Adjusted EBITDA rose 87% to $19.5 million, showing that the growth translated into operating profit rather than being purely volume-led.

MetricQ3 2026Q3 2025Consensus / Prior guidance
Revenue (Financial Highlights)$114.4M (+104%)$56.0M~$94.4M
Diluted EPS (Financial Highlights)$0.34$0.53~$0.22
Adjusted EBITDA (Non-GAAP reconciliation)$19.5M (+87%)$10.4M
Gross margin (Gross Profit)24%32%
FY revenue guidance (Guidance table)$382M-$390M$360M-$370M
FY Adjusted EBITDA guidance (Guidance table)$59M-$62M$50M-$54M

The guidance increase confirms management is seeing momentum beyond one quarter. The revenue range moved to $382 million-$390 million from $360 million-$370 million, and Adjusted EBITDA guidance rose to $59 million-$62 million from $50 million-$54 million. 〔0〕 That gives the filing more weight than a simple quarterly beat: it raises the expected baseline for the full year and provides funding for the planned 2027 Data Analytics buildout.

The main quality issue is cash conversion and margin mix. Gross margin fell to 24% from 32%, largely because last year included more high-margin minimum-purchase revenue with no associated cost. Operating cash flow was negative $16.8 million for the first nine months as receivables and inventory absorbed cash (Cash Flow statement), even though reported earnings and EBITDA improved. GAAP net income and EPS also declined year over year, but that comparison is distorted by a $12.6 million non-cash tax benefit in Q3 2025.

Bottom line: This is a clear earnings beat with another meaningful guidance increase, strengthening Flotek’s growth-and-expansion story. The caveat is that cash is still tied up in working capital and the revenue mix remains partly dependent on related-party Chemistry sales, so the next proof point is whether the higher targets convert into cash and scalable Data Analytics growth.

What to watch next

Q4 results and 2027 Data Analytics capex rollout

Original filing on SEC EDGAR

More Flotek Industries Inc/cn/ news

Flotek earnings beat estimates as 2026 guidance jumps again | FTK Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.